Skip to main content
Richard Silver, MD, Rheumatology, Charleston, SC, MUSC Health University Medical Center

RichardMSilverMD

Rheumatology Charleston, SC

Rheumatoid Arthritis & Related, Scleroderma & Related, Vasculitis

Division of Rheumatology & Immunology, Medical University of South Carolina

Dr. Silver is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Silver's full profile

Already have an account?

Education & Training

  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterFellowship, Rheumatology, 1979 - 1981
  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Internal Medicine, 1975 - 1977
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 1975

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1979 - Present
  • SC State Medical License
    SC State Medical License 1981 - 2025
  • NC State Medical License
    NC State Medical License 1975 - 2002
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Master American College of Rheumatology, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Elected Member The American Society for Clinical Investigation, 1994

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Anti-Fibrotic Peptide Shows Early Promise Against Interstitial Lung Disease
    Anti-Fibrotic Peptide Shows Early Promise Against Interstitial Lung DiseaseApril 13th, 2016

Grant Support

  • Clinical Trial: Apple StudyNational Center For Research Resources2008
  • Administrative CoreNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2007
  • Apple StudyNational Center For Research Resources2005–2007
  • Niams Clinical Research Center For Rheumatoid DiseaseNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2003–2007
  • Number Of Subjects Serum Collection (Ssc And SLE New Patients):773National Institute Of Arthritis And Musculoskeletal And Skin Diseases2006
  • Number Of Subjects BAL Studies (Patients And Controls): 112National Institute Of Arthritis And Musculoskeletal And Skin Diseases2005
  • Number Of Subjects Skin Biopsies (Patients And Controls): 120National Institute Of Arthritis And Musculoskeletal And Skin Diseases2005
  • Cyclophosphamide VS Placebo In Syst SCL Pulm AlveolitisNational Center For Research Resources2005
  • Cyclophosphamide Vs. Placebo In Syst. Scl. Pulm. AlveolitisNational Center For Research Resources2004
  • Scleroderma Lung StudyNational Heart, Lung, And Blood Institute1999–2003
  • Trial Of BAY 12-9566 In Osteoarthritis (OA) Of KneesNational Center For Research Resources2001–2002
  • Oral Cyclophosphamide VS Oral Placebo In SSC AlveolitisNational Heart, Lung, And Blood Institute2000
  • Bronchoalveolar Lavage In Connective Tissue DiseaseNational Center For Research Resources1996–2000
  • Planning Grant For A Multipurpose Clinical Research CentNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999
  • Treatment Study Of The Chronic Manifestations Of The Eosinophilia Myalgia SyndreNational Center For Research Resources1996–1997
  • Magnesium Deficiency In The Eosinophilia Myalgia SyndromeNational Center For Research Resources1994–1995
  • Mechanics Of Alveolitis In Connective Tissue DiseaseNational Center For Research Resources1993–1995
  • Controlled Study Of Cyclophosphamide In SSC Lung DiseaseNational Center For Research Resources1993
  • Tryptophan-Related Connective Tissue DiseaseNational Center For Research Resources1990–1991

Professional Memberships

Hospital Affiliations